glecaprevir: Clinical Trials

5 trials of glecaprevir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 withdrawn, 1 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Withdrawn 2, Recruiting 1

Follow glecaprevir: new trials by email Literature Review of glecaprevir trials Research Report on glecaprevir

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access
Glecaprevir / Pibrentasvir Oral Tablet [Mavyret] - End Stage Renal Disease, Chronic Hepatitis c
Phase 4WithdrawnMassachusetts General Hospital2020-11-132022-03-08
Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir
Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg) - Hepatitis C
Phase 4RecruitingKirby Institute302020-02-112026-07-29
Multi-center Study to Transplant Hepatitis-C Infected Kidneys
glecaprevir/pibrentasvir treatment - Renal Failure Chronic, Hepatitis C
Phase 4CompletedRaymond Chung302019-04-102022-01-26
Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
glecaprevir/pibrentasvir tablets - Kidney Failure, Kidney Diseases
Phase 4WithdrawnRaymond T. Chung, MD2019-02-152019-06-03
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
300mg glecaprevir/pibrentasivir 120mg - End Stage Renal Disease, Hepatitis C
Phase 4CompletedJohns Hopkins University112018-09-252021-10-19

Conditions studied

Hepatitis C (5)  ·  Kidney Failure, Chronic (2)  ·  Renal Insufficiency (2)  ·  Hepatitis C, Chronic (1)  ·  Kidney Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Johns Hopkins University (1)  ·  Kirby Institute (1)  ·  Massachusetts General Hospital (1)  ·  Raymond Chung (1)  ·  Raymond T. Chung, MD (1)

Countries

United States (4)  ·  Australia (1)

Top investigators

Raymond T Chung, MD (2)  ·  Christine Durand, MD (1)  ·  Marianne Martinello, MD, PhD (1)

Results publications

PMID 35155863